Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences

被引:40
|
作者
Kim, Bokyung [1 ]
机构
[1] Univ Texas Austin, Dept Econ, Austin, TX 78712 USA
关键词
Prescription drug monitoring program; Must-access PDMP; Opioid; Heroin; Opioid overdose; Opioid epidemic;
D O I
10.1016/j.jhealeco.2020.102408
中图分类号
F [经济];
学科分类号
02 ;
摘要
Although supply-side drug policies that limit access to legal opioids have reduced prescription opioid abuse, growing evidence shows that these policies have had the unintended consequence of increasing use of illegal opioids, including heroin. I add to this literature by studying the consequences of must-access prescription drug monitoring programs (PDMPs), which legally require providers to access a state-level database with a patient's prescription history before prescribing controlled substances under certain circumstances. Using a difference-in-differences specification, I find strong evidence that must-access PDMPs have increased heroin death rates. My estimates indicate that two years after implementation, must-access PDMPs were associated with 0.9 more heroin deaths per 100,000 in a half-year period, relative to control states. My results suggest that even if must-access PDMPs reduce prescription opioid deaths, the decrease is offset by a large increase in illegal opioid deaths. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] A comparison of an opioid abuse screening tool and prescription drug monitoring data in the emergency department
    Weiner, Scott G.
    Horton, Laura C.
    Green, Traci C.
    Butler, Stephen F.
    DRUG AND ALCOHOL DEPENDENCE, 2016, 159 : 152 - 157
  • [42] Trends in Opioid Prescribing Following Pennsylvania Statewide Implementation of a Prescription Drug Monitoring Program
    Miller, Chaim
    Ilyas, Asif M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [43] Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis
    Chang, Hsien-Yen
    Lyapustina, Tatyana
    Rutkow, Lainie
    Daubresse, Matthew
    Richey, Matt
    Faul, Mark
    Stuart, Elizabeth A.
    Alexander, G. Caleb
    DRUG AND ALCOHOL DEPENDENCE, 2016, 165 : 1 - 8
  • [44] Occult prescription opioid abuse detected by expanded urine drug screening vs. prescription monitoring program query
    McKay, C. A.
    Gerona, R. R.
    Wu, A. H.
    CLINICAL TOXICOLOGY, 2014, 52 (07) : 698 - 698
  • [45] Consumer/Patient Encounters with Prescription Drug Monitoring Programs: Evidence from a Medicaid Population
    Goodin, Amie
    Blumenschein, Karen
    Freeman, Patricia Rippetoe
    Talbert, Jeffery
    PAIN PHYSICIAN, 2012, 15 (03) : ES169 - ES175
  • [46] A population-based study on the risk of prescription opioid abuse in patients with chronic opioid use and cost-effectiveness of prescription drug monitoring program using a patient simulation model in South Korea
    Kim, Siin
    Suh, Hae Sun
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2023, 112
  • [47] Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015-2016
    Smolina, Kate
    Crabtree, Alexis
    Chong, Mei
    Zhao, Bin
    Park, Mina
    Mill, Christopher
    Schutz, Christian G.
    DRUG AND ALCOHOL DEPENDENCE, 2019, 194 : 151 - 158
  • [48] Effect of Payor-Mandated Review of Prescription Drug Monitoring Program on Opioid Prescriber Rates
    Schumann, Samuel O., III
    Zhang, Jingwen
    McCauley, Jenna L.
    Heidari, Khosrow
    Ball, Sarah J.
    SOUTHERN MEDICAL JOURNAL, 2020, 113 (09) : 415 - 417
  • [49] Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program
    Fink, Patrick B.
    Deyo, Richard A.
    Hallvik, Sara E.
    Hildebran, Christi
    PAIN MEDICINE, 2018, 19 (12) : 2481 - 2486
  • [50] Effect of a Law Requiring Prescription Drug Monitoring Program Use on Emergency Department Opioid Prescribing: A Single-Center Analysis
    Zeiner, Abigail L.
    Burak, Michelle A.
    O'Sullivan, David M.
    Laskey, Dayne
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (05) : 774 - 779